PMA Supplement Cybersecurity Changes
Which PMA submission type a cybersecurity change requires - 180-day supplement, Real-Time, Special, 30-day notice, or annual report - and the decision.
Read articleEvery article in our archive tagged Primer.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 12 of 120 articles tagged Primer · Page 2 of 10
Which PMA submission type a cybersecurity change requires - 180-day supplement, Real-Time, Special, 30-day notice, or annual report - and the decision.
Read article
How cybersecurity expectations apply to De Novo submissions under Section 524B - SPDF, SBOM, threat model, testing - and where De Novo differs from.
Read article
IEC 81001-5-1 vs AAMI SW96 compared side-by-side: scope, lifecycle vs risk focus, FDA recognition, and which to anchor your Secure Product Development.
Read article
What a real BLE/RF penetration test on a Class II connected medical device actually finds. Aligned with the FDA's Feb 3, 2026 premarket cybersecurity.
Read article
Where CAN/CANopen shows up inside medical devices, the attack paths reviewers want modeled, and the controls that actually hold up under pen test.
Read article
Why CVSS 4.0's Safety and Automatable metrics matter for patient harm, and how to handle the transition in FDA submissions and postmarket VEX statements.
Read article
Medical device cybersecurity relies on AAMI TIR57, TIR97, and SW96. Understand their applications, FDA recognition, and how to use them for compliance.
Read article
Understand the factors influencing medical device penetration testing cost, from FDA requirements to device complexity. Get a transparent pricing breakdown.
Read article
Learn the actual timelines for FDA cybersecurity review. Understand 510(k) and De Novo clock stops, RTA hold periods, and how to avoid costly delays.
Read article
The four cybersecurity deficiency patterns the FDA flags most often in 510(k) submissions - incomplete SBOMs, thin threat models, scoped-down pen tests.
Read article
Understand whether to hire a medical device security consultant or build an in-house team. Evaluate costs, FDA expertise, and submission timelines.
Read article
Cybersecurity documentation belongs in the QMS, not a side folder. What MedTech teams must create, control, and maintain across the full device lifecycle.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.